Nimbus Discovery has signed up Microsoft CEO Bill Gates and Richard Friesner, co-founder of chemical simulation software developer Schrodinger, as investors.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Charles River, AMRI and Synexus.
Merck KGaA has opened a new centre in India to showcase its range of technology solutions to the country’s rapidly expanding pharmaceutical and cosmetics industries.
SGS Life Sciences will expand bioanalytical capacity at its facility in Poitiers, France in the latest stage of its effort to become the biggest biologics testing services firm by 2014.
WuXi has received GLP certification from the SFDA for its toxicology facility in Suzhou, China and, in a separate development, is providing CAS’ SciFinder to its staff.
BioFocus has sealed two compound management deals with the National Cancer Institute and eMolecules, while extending its relationship with Chiesi Farmaceutici for $3.5m (€2.5m).
Anglo-German company Evotec is joining forces with Almirall to identify small molecule modulators of an ion channel target involved in respiratory diseases.
Chemir Analytical Services launches custom synthesis service for organic molecules for drug R&D, aimed at small pharma companies with rush or emergency projects.
A project bringing together researchers from academia and pharma companies, including GSK and AZ, has received a £709,000 ($1.09m) grant to create crystals using continuous flow production.
Lab Research (LRI) aims to boost its Korean presence in a new agency deal with Safe Chemicals that, CEO Luc Mainville says, will meet growing demand for large molecule contract R&D.
Fine chemicals firm Minakem believes that manufacturing capacity added by its newly acquired API plant in Dunkirk, France will reduce costs and help it compete on a global scale.
Lonza has felt “no negative impact” from the economic crisis and demand from clients remains strong, which will enable the company to post average growth in the high teens until 2013.
The pharmaceutical industry sometimes seems besieged from all sides at present, and that has implications for contract manufacturers, according to Stefan Borgas, CEO of Lonza, at a recent meeting of the European Fine Chemicals Group (EFCG) in Frankfurt.
You'll be unlikely to see them at your local cinema, but molecular
animations created using highly accurate information from X-ray
scattering images, will help explain how proteins and organic
molecules behave in a solution.
Syft Technologies of New Zealand released the latest generation of
Selected Ion Flow Tube-Mass Spectrometry (SIFT) instrumentation at
Pittcon 2008 for the analysis of very low levels of organic
compounds in air (detection limits as...
In any laboratory, or indeed in any pharmaceutical manufacturing
facility, one of the major expenses will be solvents. And just like
the price of petrol and diesel it just keeps going up and up.
Huw Kidwell examines how a new recycling...
US-based contract manufacturer AMRI has been busily embracing India
with the purchase and construction of infrastructure to cement
itself in this popular location, delegates heard at this year's
CPhI in Milan.
A new fluorescent chemical sensor can detect citric acid at low
concentrations more rapidly and cheaply than current optical
sensors, its developer claims.
Prosonix and Bath University in the UK have won the Royal Society
of Chemistry's (RSC) Innovation award for the development of a tool
that enables the manufacture of crystalline pharmaceuticals of
specific sizes.
Indian chemical firm Syschem is planning to splash out up to $15m
(€11.4m) over two years to expand its manufacturing capacity – a
move the company said will facilitate its smooth entry into the
pharma industry and help cope with...
LAB Research has completed a $12m facility expansion in Canada that
will increase its preclinical testing services capacity at the site
by 40 per cent.
Intertek has broadened its portfolio to offer outsourced analysis of biologics as well as small molecules by purchasing Alta Laboratories, for $25m (€18.8m).
Researchers have developed a more efficient and cost-saving method
to make cladribine, a drug used for the treatment of certain types
of leukaemia and potentially efficient against multiple sclerosis
(MS).
The Massachusetts Institute of Technology (MIT) has designed a
portable "lab on a chip" diagnostic device, which the researchers
say could identify biological or chemical weapons faster and easier
than current methods.
Using a processing technique described as "revolutionary," DSM is
accelerating its activity in the anti-infective arena and targeting
new active pharmaceutical ingredients (APIs) that it can develop
into cost-competitive...
Chemir Analytical Services, the new owner of Gateway Chemical
Technology, has renamed the custom chemical analysis business
IQsynthesis in a revamp effort.
Avalon Pharmaceuticals and ChemDiv have revealed details on a
collaboration in which the two companies are to engage in drug
discovery in the oncology sector focusing on small molecules as a
basis for therapeutic development.
Indian custom chemical synthesis firm Denisco has opened up shop in
the US to capitalise on the growing demand in North America for
high-quality, low-cost complex organic molecules.
Peakdale Molecular has taken the opportunity to expand its
capabilities and capacity extending the services it can provide to
further support customers' drug discovery challenges.
Tripos has announced the release of the latest version of its
visualisation platform that allows laboratory scientists to make
better informed decisions based on the three-dimensional molecular
information it produces.
CyBio presents its new liquid handling platform and pipetting
system at Analytica in Munich, which aims to meet customer needs in
drug discovery processes that require precision and accuracy when
handling fluid materials.
Researchers at Michigan State University have found that
second-generation taxols, which currently rely on assembly by
semisynthetic organic chemistry approaches, can be produced in a
cheap and environmentally friendly fashion using...
After branching out of the US with the opening of new facilities in
Singapore and India and a recent Eastern European acquisition,
US-based Albany Molecular Research (AMR) used Interphex 2006 to
highlight its new range of global services.
Researchers have constructed a model of an axon, which they have
used to reproduce a change in the axon's shape that is
characteristic of neurodegenerative disorders. The model provides a
new road to discovering new kinds of...
Velocity11 make available a benchtop microplate handling system
that claims to provide the features and flexibility of much larger
and more expensive automation platforms.
Outsourcing specialist Celsis Laboratory Group will provide
contract testing services for drug firms Mutual and Procter &
Gamble, advancing the company's status in this market.
US researchers have managed to create tiny chemical cages that
enclose drugs within a capsule that can be manufactured to deliver
drugs to organs or tissues without causing harm elsewhere.
Genevac announces the launch of a new second-generation version of
its EZ-2 centrifugal evaporator, which is able to take tubes,
flasks and vials directly from the synthesis process, providing
flexibility for those switching their...
A Strategic Research Agenda (SRA) was launched last week in a move
to bolster the chemistry and biotechnology industry's contribution
to European growth and competitiveness.
Avecia spin-off, Reaxa, has announced that Umicore has taken a 21
per cent stake in a move that underlines Reaxa's business strategy
in looking at joint R&D, new product development and toll
manufacturing agreements.
Arsenal Capital Partners has acquired a majority stake in Reilly
Industries for €209 million and Velsicol Chemical for an
undisclosed fee. The purchases continue a rich vein of activity for
the private equity firm, which now hold...
Researchers in France have developed a new microporous material
that could have a range of applications for the pharmaceutical
industry, including chemical separation and catalysis in medicine
manufacturing and drug delivery.
A newly discovered compound, which has revealed new links between
cell signalling pathways and cell migration, may suggest new
avenues for novel pharmaceutical therapies for treating a variety
of diseases, including cancer.
